Payer formulary tier increases of apixaban: how patients respond and potential implications

[HTML] nih.gov

[HTML][HTML] Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?

AM Sydor, E Bergin, J Kay, E Stone… - Journal of Health …, 2024 - ncbi.nlm.nih.gov
Background: Medication formularies, initially designed to promote the use of cost-effective
generic drugs, are now designed to maximize financial benefits for the pharmacy benefit …
相关文章 所有 2 个版本